Shadi Tabibian: Navigating Modern Diagnosis and Individualized Care in Hemophilia A and B
Shadi Tabibian, Deputy of research at Blood Diseases Research Centers in Iran University of Medical Sciences, shared a post on LinkedIn about a recent article by Ming Y. Lim et al, published in Journal of Thrombosis and Haemostasis, adding:
“Hemophilia A and B: From Diagnosis to Personalized Lifelong Care.
The management of hemophilia has evolved dramatically—from conventional factor replacement to extended half-life concentrates, FVIII mimetics, rebalancing agents, and gene therapy.
This recent educational review provides a comprehensive overview of:
- The genetic and pathophysiological basis of hemophilia A and B
- Clinical presentation and laboratory diagnosis
- The expanding treatment landscape
- Treatment monitoring and inhibitor management
- Hemophilic arthropathy and age-related comorbidities
- The essential role of multidisciplinary and personalized care
Despite major therapeutic advances, important challenges remain.
Inhibitor development, progressive joint disease, laboratory monitoring of novel therapies, equitable treatment access, and the growing burden of cardiovascular and other age-related conditions continue to shape clinical practice.
The key message is clear: modern hemophilia care must extend beyond bleeding control.
It should aim to preserve joint health, reduce treatment burden, improve quality of life, and support individuals with hemophilia throughout their lifespan.”
Title: Diagnosis and management of hemophilia A and B
Authors: Ming Y. Lim, Jesús Ardila, Giancarlo Castaman, Yesim Dargaud, Karin Fijnvandraat, Roberta Gualtierotti, Cedric Hermans, Susan Shapiro
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal
-
Sep 22, 2026, 18:49Abdul Rahman Hamad: Early Action for Better Outcomes in Deep Vein Thrombosis
-
Sep 22, 2026, 18:37Carmine Siniscalchi: Age-Adjusted D-Dimer Cutoffs in DVT Diagnosis
-
Sep 22, 2026, 18:37Stefano Romeo: The Cardiovascular Patient Journey is Still Full of Gaps
-
Sep 22, 2026, 18:11Bharath Kumar V.։ Advancing Safer Anticoagulation for Cancer-Associated Thrombosis
-
Sep 22, 2026, 18:10Fatima Zahra: ASH Released New Guidelines on the Diagnosis of Iron Deficiency
-
Sep 22, 2026, 17:49Nirav Dhanesha: Targeting FXI for Safer Anticoagulation
-
Sep 22, 2026, 17:17Eric Lambert: Intravascular Imaging and the Future of Precision PCI
-
Sep 22, 2026, 16:45Claudiu Stoicescu: Are We Starting Cardiovascular Risk Assessment Too Late?